CESARIO FRANK 4
4 · NANOPHASE TECHNOLOGIES Corp · Filed Nov 17, 2017
Insider Transaction Report
Form 4
CESARIO FRANK
Chief Financial Officer
Transactions
- Sale
Common Stock
2017-11-16$0.58/sh−15,453$8,963→ 83,783 total - Exercise/Conversion
Common Stock
2017-11-16$0.44/sh+15,453$6,799→ 99,236 total - Exercise/Conversion
Common Stock (right to buy)
2017-11-16$0.44/sh−15,453$6,799→ 20,547 totalExercise: $0.44From: 2016-02-18Exp: 2025-02-18→ Common Stock (15,453 underlying)
Holdings
- 20,000
Common Stock (right to buy)
Exercise: $1.07From: 2010-06-24Exp: 2019-06-24→ Common Stock (20,000 underlying) - 20,000
Common Stock (right to buy)
Exercise: $1.70From: 2011-05-03Exp: 2020-05-03→ Common Stock (20,000 underlying) - 31,000
Common Stock (right to buy)
Exercise: $1.26From: 2012-05-02Exp: 2021-05-02→ Common Stock (31,000 underlying) - 31,500
Common Stock
Exercise: $0.42From: 2017-02-23Exp: 2026-02-23→ Common Stock (31,500 underlying) - 40,000
Common Stock (right to buy)
Exercise: $0.52From: 2015-02-13Exp: 2024-02-13→ Common Stock (40,000 underlying) - 36,000
Common Stock
Exercise: $0.68From: 2018-02-21Exp: 2027-02-21→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.